Remit of the Board of Governors
The Board of Governors makes decisions on all Institut Pasteur matters. In particular, the Board:
- Gives its opinion on the strategic policies proposed by the President;
- Adopts the Annual Report on Institut Pasteur activity and submits it for the approval of the General Meeting board;
- Votes on budgets and forecasts regarding workforce headcount, with an objective of sustaining the endowment; and it approves the accounts;
- Provides a framework for assets management, notably assets forming part of the endowment;
- Determines the status and the terms of recruitment and remuneration of the foundation's employees;
- Authorizes legal proceedings;
- Appoints the Institut Pasteur President by a two-thirds majority after the Chair has consulted each member of the Scientific Council, the heads of the different scientific departments and, if deemed useful, any other competent person. It determines the President's remuneration package and terminates his or her appointment by a majority of two-thirds of the members in office;
- On proposal from the President, appoints the Vice-Presidents and Senior Executive Vice-Presidents as well as the directors of the scientific departments and terminates their appointment;
- On proposal from the President, appoints senior scientific managers to the rank of professor;
- Approves the establishment or dissolution of research units, also on proposal from the President;
- As applicable, and with a view to exploiting the findings of the Institut Pasteur's research, decides to enter into contracts with one or more companies or take a stake in an existing or newly formed company;
- Appoints one or more auditors and their deputies.
Board members and appointment criteria
1. Appointment procedure
Members are appointed as follows:
5 ex officio members:
- One representative of the French Minister for Research;
- One representative of the French Minister for the Budget;
- One representative of the French Minister for Health;
- The Chairman and CEO of the CNRS (French National Center for Scientific Research);
- The Chairman and Chief Executive Officer of Inserm (French National Institute for Health and Medical Research).
1 Member representing the partner university:
- The President of Université de Paris Cité
16 members elected at the General Meeting from either within or outside its ranks, and including:
- 4 members chosen for their scientific expertise, at least 3 of whom working at the Institut Pasteur. These members are elected on the basis of "double nominee" proposals made by the Scientific Council.
- 2 members from Institut Pasteur non-scientific staff with at least ten years' service. These members are elected on the basis of "double nominee" proposals from the Works Committee.
- 10 members not working at the Institut Pasteur, and including:
- 4 members chosen for their general, scientific or medical expertise, at least 2 of whom work or have previously worked in scientific institutions or departments;
- 6 members chosen for their financial, industrial, business, legal or management expertise.
Half the elected members appointed for six years are renewed every three years in each category.
The Board of Governors chooses a bureau from among its members, composed of a Chair, one or two Vice-Chairs, a Secretary and a Treasurer, elected during each partial board renewal process for a three-year renewable term.
The Board of Governors can delegate some of its powers to its Chair and bureau as well as to the President.
On October 28, 2022, following the replacement of outgoing members at the last session of the General Meeting, the Institut Pasteur Board of Governors elected its new Chairman, Yves Saint-Geours.
2.1 Board of Governors
- Chair: Yves Saint-Geours, Senior Minister Plenipotentiary, former Ambassador
- Vice-Chair: Artur Scherf, Head of the Institut Pasteur's Biology of Host–Parasite Interactions Unit
- Vice-Chair: Stéphanie Fougou, General Counsel and Corporate Secretary at Technicolor
Ex officio members:
- Didier Samuel, Chairman and Chief Executive Officer of Inserm (French National Institute for Health and Medical Research)
- Louis de Franclieu, Deputy Director (3rd sub-directorate) in the Budget Division
- Bertrand Schwartz, Deputy Scientific Director Biology and Health Dpt, Directorate General for Research and Innovation, French Minister of Higher Education and Research (MESR)
- Antoine Petit, Chairman and CEO of the French National Center for Scientific Research (CNRS)
- Jérôme Salomon, Director-General for Health in the French General Directorate of Health
Member representing the partner university:
- Christine Clerici, President of Université Paris Cité
Members chosen for their scientific expertise, at least three of whom work at the Institut Pasteur:
- Sandrine Étienne-Manneville, Head of the Cell Polarity, Migration and Cancer Unit, Institut Pasteur
- Jean-Claude Manuguerra, Head of the Environment and Infectious Risks Research and Expertise Unit, Institut Pasteur
- Artur Scherf, Head of the Biology of Host–Parasite Interactions Unit, Institut Pasteur
- Félix Rey, Head of the Structural Virology Unit, Institut Pasteur
Members from Institut Pasteur non-scientific staff with at least ten years' service:
- Virginie Ponticelli, Head of the "Administrative Coordination of Education: Courses, Projects and Innovation" Section, Institut Pasteur
- Agnès Raymond-Denise, Head of the Scientific Information Resources Center, Institut Pasteur
Members chosen for their general, scientific or medical expertise, at least two of whom work or have previously worked in scientific institutions or departments:
- Geneviève Almouzni, CNRS Director of Research, team leader at the Institut Curie
- Marie-Hélène Verlhac, CNRS Director of Research – Center for Interdisciplinary Research in Biology (CIRB), Collège de France
- Patrick Charnay, Professor at the École Normale Supérieure (ENS), Inserm Emeritus Director of Research
- Fabiola Terzi, Institut Necker-Enfants Malades Director, Inserm Director of Research
Members chosen for their financial, industrial, business, legal or management expertise:
- Stéphanie Fougou, General Counsel and Corporate Secretary at Technicolor
- Delphine D'Amarzit, Chairman and CEO of Euronext Paris
- André Choulika, CEO and Co-Founder of the Cellectis Group
- Inès-Claire Mercereau, Chief Advisor to the French Government's Accounting Office
- Yves Saint-Geours, Senior Minister Plenipotentiary, former Ambassador
- Catherine Touvrey, CEO of Harmonie Mutuelle
2.2 Board of Governors Bureau
- Chair: Yves Saint-Geours
- Vice-Chair: Artur Scherf
- Vice-Chair: Stéphanie Fougou
- Treasurer: Louis de Franclieu
- Secretary: Sandrine Étienne-Manneville
- Permanent guest: Patrick Charnay
All Bureau meetings are attended by the Chairs of the Appointments and Remuneration Committee and the Finance and Audit Committee, Catherine Touvrey and Inès-Claire Mercereau.
2.3 Appointments and Remuneration Committee
The Appointments and Remuneration Committee provides support and expertise to the Bureau and Board of Governors in all matters relating to the development and implementation of remuneration policy as well as the monitoring of budget items (mandatory annual negotiations, payroll and headcount). The Committee examines and issues opinions and recommendations on the recruitment and remuneration of members of the Senior Management Board (CODIR) and any person with a gross annual salary exceeding €100,000.
- Chair: Catherine Touvrey
- Member: Jean-Claude Manuguerra
- Member: Stéphanie Fougou
2.4 Finance and Audit Committee
The Finance and Audit Committee supports the Board of Governors in its mission to oversee the Institut Pasteur's management (budget preparation and monitoring, accounts closing, monitoring of assets management, overall risk control measures).
- Chair: Inès-Claire Mercereau
- Member: Louis de Franclieu
- Member: André Choulika
- Member: Virginie Ponticelli
2.5 Board representatives on the Investment Advisory Committee
- Inès-Claire Mercereau
- André Choulika
2.6 Board representative on the Ethics and Compliance Committee
- Geneviève Almouzni
This English version is for information only, it does not have any legal value.
The French version prevails.